Intensity Therapeutics Shares Drop 4.18% as Market Caps at $10.7 M
Intensity Therapeutics shares fall 4.2% amid a steep 21.6% year‑to‑month decline; the biotech’s 10.7M market cap, $3.19 price, and 52‑week low at $3.10 highlight key investor insights.
- INTENSITY THERAPEUTICS INC
- United States
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
2 minutes to read